BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

362 related articles for article (PubMed ID: 29856501)

  • 1. Apolipoprotein B mRNA editing enzyme catalytic polypeptide-like family genes activation and regulation during tumorigenesis.
    Gao J; Choudhry H; Cao W
    Cancer Sci; 2018 Aug; 109(8):2375-2382. PubMed ID: 29856501
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apolipoprotein B mRNA Editing Enzyme, Catalytic Polypeptide-Like Gene Expression, RNA Editing, and MicroRNAs Regulation.
    Cao W; Wu W
    Methods Mol Biol; 2018; 1699():75-81. PubMed ID: 29086369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNAs regulate APOBEC gene expression.
    Cao W; Wu W
    Histol Histopathol; 2018 Feb; 33(2):117-120. PubMed ID: 28604942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Addressing the benefits of inhibiting APOBEC3-dependent mutagenesis in cancer.
    Petljak M; Green AM; Maciejowski J; Weitzman MD
    Nat Genet; 2022 Nov; 54(11):1599-1608. PubMed ID: 36280735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The cytidine deaminases AID and APOBEC-1 exhibit distinct functional properties in a novel yeast selectable system.
    Krause K; Marcu KB; Greeve J
    Mol Immunol; 2006 Feb; 43(4):295-307. PubMed ID: 15963568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. APOBEC3: Friend or Foe in Human Papillomavirus Infection and Oncogenesis?
    Warren CJ; Santiago ML; Pyeon D
    Annu Rev Virol; 2022 Sep; 9(1):375-395. PubMed ID: 35671565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. APOBEC3-mediated mutagenesis in cancer: causes, clinical significance and therapeutic potential.
    Butler K; Banday AR
    J Hematol Oncol; 2023 Mar; 16(1):31. PubMed ID: 36978147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RNA-editing cytidine deaminase Apobec-1 is unable to induce somatic hypermutation in mammalian cells.
    Eto T; Kinoshita K; Yoshikawa K; Muramatsu M; Honjo T
    Proc Natl Acad Sci U S A; 2003 Oct; 100(22):12895-8. PubMed ID: 14559972
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Mutagenic Activity of AID/APOBEC Deaminases in Antiviral Defense and Carcinogenesis].
    Shilova ON; Tsyba DL; Shilov ES
    Mol Biol (Mosk); 2022; 56(1):55-68. PubMed ID: 35082258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Associations between activation-induced cytidine deaminase/apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like cytidine deaminase expression, hepatitis B virus (HBV) replication and HBV-associated liver disease (Review).
    He X; Li J; Wu J; Zhang M; Gao P
    Mol Med Rep; 2015 Nov; 12(5):6405-14. PubMed ID: 26398702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Roles of APOBEC3A and APOBEC3B in Human Papillomavirus Infection and Disease Progression.
    Warren CJ; Westrich JA; Doorslaer KV; Pyeon D
    Viruses; 2017 Aug; 9(8):. PubMed ID: 28825669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An APOBEC cytidine deaminase mutagenesis pattern is widespread in human cancers.
    Roberts SA; Lawrence MS; Klimczak LJ; Grimm SA; Fargo D; Stojanov P; Kiezun A; Kryukov GV; Carter SL; Saksena G; Harris S; Shah RR; Resnick MA; Getz G; Gordenin DA
    Nat Genet; 2013 Sep; 45(9):970-6. PubMed ID: 23852170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human APOBEC3 Variations and Viral Infection.
    Sadeghpour S; Khodaee S; Rahnama M; Rahimi H; Ebrahimi D
    Viruses; 2021 Jul; 13(7):. PubMed ID: 34372572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apolipoprotein B messenger RNA editing: insights into the molecular regulation of post-transcriptional cytidine deamination.
    Davidson NO; Anant S; MacGinnitie AJ
    Curr Opin Lipidol; 1995 Apr; 6(2):70-4. PubMed ID: 7773570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apobec-1 and apolipoprotein B mRNA editing.
    Chan L; Chang BH; Nakamuta M; Li WH; Smith LC
    Biochim Biophys Acta; 1997 Mar; 1345(1):11-26. PubMed ID: 9084497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The interesting relationship between APOBEC3 deoxycytidine deaminases and cancer: a long road ahead.
    Granadillo Rodríguez M; Flath B; Chelico L
    Open Biol; 2020 Dec; 10(12):200188. PubMed ID: 33292100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. C-->U editing of neurofibromatosis 1 mRNA occurs in tumors that express both the type II transcript and apobec-1, the catalytic subunit of the apolipoprotein B mRNA-editing enzyme.
    Mukhopadhyay D; Anant S; Lee RM; Kennedy S; Viskochil D; Davidson NO
    Am J Hum Genet; 2002 Jan; 70(1):38-50. PubMed ID: 11727199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Post-transcriptional regulation of LINE-1 retrotransposition by AID/APOBEC and ADAR deaminases.
    Orecchini E; Frassinelli L; Galardi S; Ciafrè SA; Michienzi A
    Chromosome Res; 2018 Mar; 26(1-2):45-59. PubMed ID: 29396793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Understanding the regulation of APOBEC3 expression: Current evidence and much to learn.
    Covino DA; Gauzzi MC; Fantuzzi L
    J Leukoc Biol; 2018 Mar; 103(3):433-444. PubMed ID: 29345375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. APOBEC-2, a cardiac- and skeletal muscle-specific member of the cytidine deaminase supergene family.
    Liao W; Hong SH; Chan BH; Rudolph FB; Clark SC; Chan L
    Biochem Biophys Res Commun; 1999 Jul; 260(2):398-404. PubMed ID: 10403781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.